Filing Flows

Filing Flows › Bicycle Therapeutics (BCYC) › Next earnings date

Bicycle Therapeutics (BCYC) earnings: beat the estimate

Bicycle Therapeutics (BCYC) reported on Oct 29, 2026 and beat the EPS estimate: −$0.15 against −$0.46 (+67.3%). Revenue was $34.1M for Q3 2026, +190% year over year. It beat the EPS estimate in 60% of the quarters on record.

Last result+67.3% vs estimate
Beat rate60%

The last report

Bicycle Therapeutics reported revenue of $34.1M for the third quarter 2026 (+190% Y/Y), net loss $10.5M. How it makes money → · Every quarter →

Bicycle Therapeutics: EPS against the estimate, last 5 reportsBicycle Therapeutics: EPS against the estimate, last 5 reportsEstimateReported−$1.07−$0.85Oct 25−$0.95−$0.29Mar 26−$0.65−$0.87Apr 26−$0.58−$0.72Jul 26−$0.46−$0.15Oct 26
Latest (Oct 26): Estimate −$0.46, Reported −$0.15.

Bicycle Therapeutics' latest quarter

Bicycle Therapeutics, Q3 2026: revenue $34.1M (+190% year over year), operating margin -39.6%, net loss $10.5M, operating cash flow −$40.3M. The chart follows the revenue to costs, profit and cash.

Questions

Did Bicycle Therapeutics beat earnings?

Bicycle Therapeutics (BCYC) reported on Oct 29, 2026 and beat the EPS estimate: −$0.15 against −$0.46 (+67.3%).

When does BCYC report earnings?

The next date is not set yet.

Does Bicycle Therapeutics usually beat earnings?

It beat the consensus EPS estimate in 60% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.